WO2025094142 - ASSAY AND RELATED METHODS, KITS AND DEVICES
National phase entry is expected:
Publication Number
WO/2025/094142
Publication Date
08.05.2025
International Application No.
PCT/IB2024/060832
International Filing Date
01.11.2024
Title **
[English]
ASSAY AND RELATED METHODS, KITS AND DEVICES
[French]
DOSAGE ET DISPOSITIF, KITS ET PROCÉDÉS ASSOCIÉS
Applicants **
BIO PREVENTIVE MEDICINE CORP.
Inventors
TSENG, Tzu-Ling
HUANG, Chi-Hsuan
CHANG, Cherng-Shyang
SHAN, Yan-Shen
Priority Data
18/385,999
01.11.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2610 | |
| EPO | Filing, Examination, Granting | 16283 | |
| Japan | Filing, Examination, Granting | 2626 | |
| South Korea | Filing, Examination, Granting | 3108 | |
| USA | Filing, Examination, Granting | 6340 |
Total:
30,967
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present disclosure is related to a method of assessing a probability of an occurrence of a cancer, in which the method may comprise obtaining respective cancer-associated polynucleotide levels based on a plurality of different cancer-associated polynucleotide molecules and respective reference polynucleotide levels based on a plurality of different reference polynucleotide molecules, adjusting the respective cancer-associated polynucleotide levels based on the respective reference polynucleotide levels, assigning coefficients to the adjusted cancer-associated polynucleotide levels, respectively, and assessing the probability of the occurrence of the cancer, based on the adjusted cancer-associated polynucleotide levels and the assigned coefficients.[French]
La présente divulgation concerne un procédé d'évaluation d'une probabilité d'apparition d'un cancer, le procédé pouvant comprendre l'obtention de niveaux polynucléotidiques respectifs associés au cancer sur la base d'une pluralité de différentes molécules polynucléotidiques associées au cancer et de niveaux polynucléotidiques de référence respectifs sur la base d'une pluralité de différentes molécules polynucléotidiques de référence, l'ajustement des niveaux polynucléotidiques associés au cancer respectifs sur la base des niveaux polynucléotidiques de référence respectifs, l'attribution de coefficients aux niveaux polynucléotidiques ajustés associés au cancer, respectivement, et l'évaluation de la probabilité d'apparition du cancer, sur la base des niveaux polynucléotidiques ajustés associés au cancer et des coefficients attribués.